Latest KFF Health News Stories
After Her Skiing Accident, An Uphill Battle Over Snowballing Bills
She took a bad fall on the slopes and her surgeon used a metal plate to put the splintered bones of her leg back together. When that device failed less than four months later, she and her insurer had to pay full price for the replacement plate.
Health Care Is Where The Jobs Are. But What Kind Of Jobs?
The health care industry adds thousands of jobs to the economy each month. While they aren’t all doctors and nurses, they aren’t all paper pushers either.
A federal district judge in Texas ruled Friday that Congress’ 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. What happens now? KHN’s Julie Rovner, along with panelists Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post, discuss the bombshell decision and its potential fallout.
Health Suffers Deep In The Troubled Heart Of Texas
The Lone Star State is an economic powerhouse, yet it fails to take care of its residents’ health and is home to some of the most extreme entrepreneurial medical practices.
Health Care Industry ‘Pays Tribute’ To California’s Influential Lawmakers
The leaders of California’s legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
Judge Strikes Down ACA Putting Law In Legal Peril — Again
The case is not expected to have an immediate effect on coverage for people who buy plans on the federal health law marketplaces because the case is likely to go to the Supreme Court — the third time that the justices will decide the fate of the landmark health law.
Feds Say California May Have Spent Nearly $1B On Ineligible Medi-Cal Beneficiaries
The potentially improper payments occurred in 2014 and 2015, when the state says it was under pressure from a massive influx of new applicants due to the Affordable Care Act’s Medicaid expansion.
Nurse Denied Life Insurance Because She Carries Naloxone
The U.S. surgeon general has called on “bystanders” to be equipped with the opioid reversal drug to save lives. But when a nurse answered that call, her application for life insurance was denied. Why?
Feds Join Lawsuit Alleging Sutter Health Padded Revenue With False Patient Data
The whistleblower complaint says that Sutter, one of the largest health systems in the U.S., exaggerated how sick certain Medicare patients were in order to collect higher payments from the government-funded program.
In California, Doctors Accused Of Sexual Misconduct Often Get Second Chances
The state medical board grants probation in more than a third of cases, a KHN analysis found. Even as other institutions adapt to lessons of the #MeToo movement, the board plans no significant changes, saying it has always prioritized discipline for sexual misconduct.
Sign-ups for insurance under the Affordable Care Act are still well behind last year’s mark with just a week until the end of open enrollment in most states. The Supreme Court declines a case that could have allowed states to defund Planned Parenthood. And the Trump administration gets hundreds of thousands of comments about its proposed changes to immigration rules that could penalize people who use government-funded health care and other social service programs. Alice Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week.
For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs
It’s a little-known secret that patients can get thousands of dollars directly from a drugmaker.
One Implant, Two Prices. It Depends On Who’s Paying.
Breast implants — used for both cancer and cosmetic surgeries — give a glimpse into how hospitals mark up prices of medical devices to increase their bottom lines.
Need Health Insurance? The Deadline Is Dec. 15
Enrollment is lagging compared with last year’s pace. But experts say sign-ups tend to accelerate as the deadline nears, and many people will be automatically re-enrolled, so the final numbers could approach last year’s totals.
More Than Half Of California Nursing Homes Balk At Stricter Staffing Rules
Patient advocates say the state’s new staffing regulations are a good start toward better protecting the frail, but the nursing home industry contends they’re too burdensome.
Podcast: KHN’s ‘What The Health?’ Is Health Spending The Next Big Political Issue?
Diabetics dying because they can’t afford insulin. Organ transplant patients undergoing “wallet biopsies” to get on waiting lists. Are out-of-pocket costs going to dominate the health discussion in the next election? Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss this as well as new Trump administration rules giving states the ability to make major changes to the Affordable Care Act. Also, lame-duck lawmakers in Wisconsin and Michigan try to cement health changes before Democrats take over.
No Cash, No Heart. Transplant Centers Require Proof Of Payment.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say “wallet biopsies” are common.
Without Obamacare Penalty, Think It’ll Be Nice To Drop Your Plan? Better Think Twice
If you’re among the millions of people expected to forgo health insurance next year when the Affordable Care Act tax penalty goes away, the financial consequences could be dire if you need unexpected medical care.
Medicare Cuts Payments To Nursing Homes Whose Patients Keep Ending Up In Hospital
The incentive program to discourage nursing homes from discharging patients too quickly will also give bonuses to facilities with fewer rehospitalizations.
Government Investigation Finds Flaws In the FDA’s Orphan Drug Program
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
